JFL Life Sciences Limited (NSE:JFLLIFE)
11.25
+0.30 (2.74%)
At close: Mar 6, 2026
JFL Life Sciences Market Cap
JFL Life Sciences has a market cap or net worth of 371.2 million as of March 6, 2026. Its market cap has decreased by -48.98% in one year.
Market Cap
371.20M
Enterprise Value
461.32M
Revenue
744.78M
Ranking
n/a
PE Ratio
14.05
Stock Price
11.25
Market Cap Chart
Since September 8, 2022, JFL Life Sciences's market cap has decreased from 731.40M to 371.20M, a decrease of -49.25%. That is a compound annual growth rate of -17.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 361.30M | -12.40% |
| Dec 31, 2025 | 412.44M | -59.35% |
| Dec 30, 2024 | 1.01B | 122.29% |
| Dec 29, 2023 | 456.44M | 22.06% |
| Dec 30, 2022 | 373.95M | -48.87% |
| Sep 8, 2022 | 731.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mangalam Drugs & Organics | 487.98M |
| Rajnish Wellness | 436.60M |
| Walpar Nutritions | 427.27M |
| Panjon | 426.02M |
| Murae Organisor | 371.79M |
| Welcure Drugs and Pharmaceuticals | 370.78M |
| Vista Pharmaceuticals | 369.31M |
| Sandu Pharmaceuticals | 336.20M |